Page 8 - DIGITAL e-Book RCPH 2026
P. 8
a
n
i
g
Organised by: :
O
r
b
y
s
e
d
1 REGIONAL CONFERENCE onon
C
N
O
N
O
L
A
F
E
C
R
E
N
E
E
R
G
I
1
st st
O
I
C
E
S
I
R
L
A
H
T
N
E
H
A
C
I
E
L
H
I
S
E
T
P P
O
N
H
R
PRECISION HEALTH
K K E Y H I G H L I G H T S
G
H
I
L
I
G
T
Y
E
H
KEY HIGHLIGHTSS
H
Launching of the Malaysian Pangenome
Keynote and Plenary Lectures
Malaysia’s national roadmap for precision health
From genomes to outcomes: Closing the last mile
Asia-optimized population multi-omics – from SG100K PRECISE
Reprogramming the heart: precision cardiology
Cardio-renal-metabolic precision in type 2 diabetes
Precision medicine and health: Health economics perspectives
Precision public health approach for tackling NCDs
Precision for all: Hope, equity, and sustainability in LMICs
Symposia: Precision Medicine
Pharmacogenomics in practice
Rapid WGS for rare diseases and critically ill patients
Precision oncology at scale
Unlocking the power of multimodal datasets
Genomic newborn screening
Precision oncology approach for Nasopharyngeal Carcinoma
Unlocking actionable variants: Comprehensive genomic panel testing
Illumina insight ecosystem: The path from innovation to impact
Trusted research environments
One assay, comprehensive insights
Precision oncology initiative under the BGSI genomics program
Liquid biopsy for colorectal cancer (CRC)
Precision cardiometabolic prevention in Singapore
From microbial potential to activity
Beyond genomics: Proteomics and metabolomics
Genetics of parkinsonism: Towards precision management
Symposia: Precision Public Health
Deployment of AI driven mammogram for breast cancer screening
Colorectal screening – past, present and the next decade
From apps & wearables to policy: Enhancing physical activity
From apps to access: Digital triage and community pathways
From one-size-fits-all to risk-stratified care
National-scale AI and Genomics
From community to clinic: How population Cohorts power precision health
Indigenous & rural health perspectives – Inclusion without exploitation
Avoiding discrimination from genetic testing – Ensuring fairness
Right test, right price, right now: An industry playbook
Precision health – cost-effectiveness analysis
Seeing health in place: Geospatial analytics
Precision public health at scale: HTA and budget impact analysis
From bytes to bedside: Building big data competencies
Data sharing policies – What, how, why, and where
Trust, security, and access: Operating population Biobanks
Industry Talks
Precision medicine for diabetes using hiPSC
Advancing precision health with integrated Multi-Omics Technologies

